Chollet C, Andre B, Voglimacci M, et al. Perinatal outcomes of second trimester antenatal genital bleeding. Clin Exp Obstet Gynecol. 2020;47(1):105-110.
Harlev A, Levy A, Zaulan Y, et al. Idiopathic bleeding during the second half of pregnancy as a risk factor for adverse perinatal outcome. J Matern Fetal Neonatal Med. 2008;21(5):331-335.
McCormack RA, Doherty DA, Magann EF, et al. Antepartum bleeding of unknown origin in the second half of pregnancy and pregnancy outcomes. BJOG. 2008;115(11):1451-1457.
Bhandari S, Raja EA, Shetty A, et al. Maternal and perinatal consequences of antepartum haemorrhage of unknown origin. BJOG. 2014;121(1):44-50.
Gyamfi-Bannerman C. Society for Maternal-Fetal Medicine (SMFM) consult series #44: management of bleeding in the late preterm period. Am J Obstet Gynecol. 2018;218(1):B2-B8.
Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol. 2006;107(4):927-941.
Timor-Tritsch IE, Yunis RA. Confirming the safety of transvaginal sonography in patients suspected of placenta previa. Obstet Gynecol. 1993;81(5 pt 1):742-744.
Shipp TD, Poder L, Feldstein VA, et al.; Expert Panel on GYN and OB Imaging. ACR Appropriateness Criteria second and third trimester vaginal bleeding. J Am Coll Radiol. 2020;17(11S):S497-S504.
Boisramé T, Sananès N, Fritz G, et al. Placental abruption: risk factors, management and maternal-fetal prognosis. Cohort study over 10 years. Eur J Obstet Gynecol Reprod Biol. 2014;179:100-104.
Silver RM. Abnormal placentation: placenta previa, vasa previa, and placenta accreta. Obstet Gynecol. 2015;126(3):654-668.
King LJ, Dhanya Mackeen A, Nordberg C, et al. Maternal risk factors associated with persistent placenta previa. Placenta. 2020;99:189-192.
Oyelese Y, Javinani A, Shamshirsaz AA. Vasa previa. Obstet Gynecol. 2023;142(3):503-518.
Al-Zirqi I, Stray-Pedersen B, Forsén L, et al. Uterine rupture: trends over 40 years. BJOG. 2016;123(5):780-787.
Sakornbut E, Leeman L, Fontaine P. Late pregnancy bleeding. Am Fam Physician. 2007;75(8):1199-1206.
Brandt JS, Ananth CV. Placental abruption at near-term and term gestations: pathophysiology, epidemiology, diagnosis, and management. Am J Obstet Gynecol. 2023;228(5S):S1313-S1329.
Jain V, Chari R, Maslovitz S, et al.; Maternal Fetal Medicine Committee. Guidelines for the management of a pregnant trauma patient. J Obstet Gynaecol Can. 2015;37(6):553-574.
Shinde GR, Vaswani BP, Patange RP, et al. Diagnostic performance of ultrasonography for detection of abruption and its clinical correlation and maternal and foetal outcome. J Clin Diagn Res. 2016;10(8):QC04-QC07.
Jenabi E, Salimi Z, Bashirian S, et al. The risk factors associated with placenta previa: an umbrella review. Placenta. 2022;117:21-27.
American College of Obstetricians and Gynecologists; Society for Maternal-Fetal Medicine. Obstetric care consensus no. 7: placenta accreta spectrum. Obstet Gynecol. 2018;132(6):e259-e275.
Einerson BD, Healy AJ, Lee A, et al.; SMFM Patient Safety and Quality Committee. Society for Maternal-Fetal Medicine special statement: emergency checklist, planning worksheet, and system preparedness bundle for placenta accreta spectrum. Am J Obstet Gynecol. 2024;230(1):B2-B11.
Fan D, Wu S, Liu L, et al. Prevalence of antepartum hemorrhage in women with placenta previa: a systematic review and meta-analysis. Sci Rep. 2017;7:40320.
McGoldrick E, Stewart F, Parker R, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2020;12(12):CD004454.
Committee on Obstetric Practice. Committee opinion no. 713: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2017;130(2):e102-e109.
Reddy UM, Deshmukh U, Dude A, et al. Society for Maternal-Fetal Medicine consult series #58: use of antenatal corticosteroids for individuals at risk for late preterm delivery: replaces SMFM statement #4, implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery, August 2016. Am J Obstet Gynecol. 2021;225(5):B36-B42.
Jansen C, de Mooij YM, Blomaard CM, et al. Vaginal delivery in women with a low-lying placenta: a systematic review and meta-analysis. BJOG. 2019;126(9):1118-1126.
Ornaghi S, Vaglio Tessitore I, Vergani P. Pregnancy and delivery outcomes in women with persistent versus resolved low-lying placenta in the late third trimester. J Ultrasound Med. 2022;41(1):123-133.
Zhang W, Geris S, Al-Emara N, et al. Perinatal outcome of pregnancies with prenatal diagnosis of vasa previa: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2021;57(5):710-719.
Fishel Bartal M, Sibai BM, Ilan H, et al. Prenatal diagnosis of vasa previa: outpatient versus inpatient management. Am J Perinatol. 2019;36(4):422-427.
Vandenberghe G, Vierin A, Bloemenkamp K, et al. Incidence and outcomes of uterine rupture in women with unscarred, preterm or prelabour uteri: data from the International Network of Obstetric Survey Systems. BJOG. 2023;130(12):1493-1501.
Deshmukh U, Denoble AE, Son M. Trial of labor after cesarean, vaginal birth after cesarean, and the risk of uterine rupture: an expert review. Am J Obstet Gynecol. 2024;230(3S):S783-S803.
ACOG practice bulletin no. 205: vaginal birth after cesarean delivery. Obstet Gynecol. 2019;133(2):e110-e127.
Holmgren C, Scott JR, Porter TF, et al. Uterine rupture with attempted vaginal birth after cesarean delivery: decision-to-delivery time and neonatal outcome. Obstet Gynecol. 2012;119(4):725-731.